University of Vermont
University of Vermont
Burlington, Vermont, United States9 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| MAPT Protocol: Fixation Versus Arthroplasty Surgical Treatments for Early Recovery After HIP Fracture (FASTER-HIP) | Femoral Fractures, Hip Injuries, Leg Injuries, bone fracture, femoral neck fracture, hip fracture, injury | Recruiting | Not applicable | 2026-10-05 | NCT07244211 | |
| Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Response | primary central nervous system lymphoma | Recruiting | Phase 2 | 2026-09-23 | NCT06175000 | |
| Generic Database of Very Low Birth Weight Infants | Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, pregnancy disorder | Recruiting | Not stated | 2026-03-16 | NCT00063063 | |
| Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy | Chemotherapy-induced Peripheral Neuropathy | Recruiting | Not applicable | 2026-03-10 | NCT04763356 | |
| REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation | Anal Cancer, Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, anus disorder, anus neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 2 / Phase 3 | 2025-12-18 | NCT05902533 | |
| Phase 1 Trial of Endobronchial Ultrasound-Guided Transbronchial Needle Injection of Cisplatin for Stage IV Lung Cancer | Lung Cancer Metastatic | Active, not recruiting | Phase 1 | 2025-10-31 | NCT04311762 | |
| Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis | CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder | Active, not recruiting | Not stated | 2025-10-02 | NCT04495556 | |
| Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes | Chemically-Induced Disorders, nicotine dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2025-06-27 | NCT06614504 | |
| LEMURS SSI: Evaluation of Behavioral Incentives | Incentives | Recruiting | Phase 1 | 2024-04-02 | NCT06340841 |